Belinda Khou
Physician Assistant · San Pedro, CANPI 1659980233
Payments from drug & device makers
Across 216 payments — averaging $99.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$18K
- Lilly USA, LLC$635
- Gilead$605
- Novo Nordisk$463
- AbbVie$456
- Viiv Healthcare Company$229
- plus $2K from 21 others
What the payments were for
- Consulting fees$9,52844%
- Speaking & faculty fees$2,66712%
- Travel & lodging$4,20020%
- Food & beverage$5,12824%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 93 | $17,617 |
| Lilly USA, LLC | 17 | $635 |
| Gilead | 17 | $605 |
| Novo Nordisk | 14 | $463 |
| AbbVie | 17 | $456 |
| Viiv Healthcare Company | 7 | $229 |
| AstraZeneca | 9 | $224 |
| Johnson & Johnson | 8 | $180 |
| Indivior Inc. | 5 | $144 |
| Sanofi-aventis U.S. LLC | 1 | $125 |
| Medtronic | 2 | $123 |
| Amgen | 1 | $118 |
| Braeburn Inc. | 3 | $82 |
| Madrigal Pharmaceuticals | 2 | $77 |
| Pfizer | 3 | $60 |
| Sage Therapeutics, LLC | 2 | $56 |
| Organon | 2 | $51 |
| Alkermes, Inc. | 2 | $45 |
| Bayer | 2 | $31 |
| Dexcom, Inc. | 1 | $28 |
| Merck | 2 | $27 |
| Sanofi Pasteur Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $25 |
| GSK | 1 | $25 |
| Masimo Corporation | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cologuard Collection Kit$9,856
- The Cologuard Plus Collection Kit$3,146
- MOUNJARO$248
- Biktarvy$150
- Descovy$121
- Repatha$118
- RYBELSUS$113
- Wegovy$110
- MINIMED 780G$108
How this compares
$21,524 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 31 | $41,203 |
| JardianceEmpagliflozin | 33 | $34,647 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,322 |
| Atorvastatin Calcium | 88 | $803 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $682 |
| Metformin Hcl | 55 | $585 |
| Losartan Potassium | 54 | $506 |
| Simvastatin | 19 | $278 |
| Amlodipine Besylate | 44 | $252 |
| Lisinopril | 32 | $221 |
| Levothyroxine Sodium | 14 | $203 |
| Gabapentin | 35 | $187 |
| Diclofenac Sodium | 14 | $176 |
| Ibuprofen | 28 | $163 |
| Famotidine | 22 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $635 | $41,20331 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in San Pedro
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.